Zargis Receives Additional Contracts from U.S. Army

PRINCETON, N.J., Oct. 9  /PRNewswire/ -- Zargis Medical Corp., a spin-off from Siemens Corporate Research, a division of Siemens AG (NYSE:SI), and a majority-owned subsidiary of Speedus Corp. (NASDAQ:SPDE), today announced that it was awarded six additional contracts from the U.S. Army totaling $270,000. Included in these awards is $170,000 of orders for nine upgraded versions of the telemedicine pilot-systems which Zargis delivered to the Army earlier this year. Based on the Army's successful evaluation of the initial prototypes in a large military hospital, they have decided to expand the scope of the project and purchase these additional units.

The upgraded systems provide improved data collection quality and are designed to record, synchronize and analyze heart sounds, lung sounds, ECG signals and, in some cases, blood oxygen saturation levels from patients being cared for by remote military treatment facilities located throughout the Pacific Rim. The systems will be fully integrated with an existing Army telehealth platform.

"We're very pleased by the success of the prototype telemedicine systems delivered to the Army earlier this year," stated Zargis CEO John Kallassy. "The demand for medical systems designed to remotely project the expertise of cardiologists and other medical specialists is growing very rapidly -- within both military and civilian environments worldwide -- and it is for this reason that Zargis has identified the field of telemedicine as a key focus area for commercialization of our products."

About Zargis Medical Corp.

Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE:SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds.

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or , or visit the following Web sites: http://www.zargis.com/ and http://www.speedus.com/.

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts. 

DATASOURCE: Zargis Medical Corp.



CONTACT:  Peter Hodge, 888-773-3669 (ext. 23),  



Web site:  http://www.speedus.com/

http://www.zargis.com/ 

Copyright